= 0 1 0 1 O
< 1 2 1 2 O
2 3 4 3 4 B-upper_bound
lines 5 10 5 10 O
of 11 13 11 13 O
prior 14 19 14 19 B-treatment
systemic 20 28 20 28 I-treatment
therapy 29 36 29 36 I-treatment
for 37 40 37 40 O
metastatic 41 51 41 51 B-cancer
disease 52 59 52 59 I-cancer
( 60 61 60 61 O
if 61 63 61 63 O
patients 64 72 64 72 O
have 73 77 73 77 O
metastatic 78 88 78 88 O
disease 89 96 89 96 O
) 96 97 96 97 O

= 0 1 98 99 O
< 1 2 99 100 O
2 3 4 101 102 B-upper_bound
lines 5 10 103 108 O
of 11 13 109 111 O
prior 14 19 112 117 B-treatment
systemic 20 28 118 126 I-treatment
therapy 29 36 127 134 I-treatment
for 37 40 135 138 I-treatment
patients 41 49 139 147 I-treatment
with 50 54 148 152 I-treatment
progressive 55 66 153 164 I-treatment
locally 67 74 165 172 I-treatment
- 74 75 172 173 I-treatment
advanced 75 83 173 181 I-treatment
disease 84 91 182 189 I-treatment

Absolute 0 8 190 198 B-clinical_variable
neutrophil 9 19 199 209 I-clinical_variable
count 20 25 210 215 I-clinical_variable
> 26 27 216 217 O
= 27 28 217 218 O
1500 29 33 219 223 B-lower_bound
/ 33 34 223 224 I-lower_bound
uL 34 36 224 226 I-lower_bound

Active 0 6 227 233 O
venous 7 13 234 240 B-chronic_disease
thrombosis 14 24 241 251 I-chronic_disease
with 25 29 252 256 O
contraindication 30 46 257 273 O
for 47 50 274 277 O
anticoagulation 51 66 278 293 B-treatment

Any 0 3 294 297 O
history 4 11 298 305 O
or 12 14 306 308 O
presence 15 23 309 317 O
of 24 26 318 320 O
poorly 27 33 321 327 O
controlled 34 44 328 338 O
gastrointestinal 45 61 339 355 B-chronic_disease
disorders 62 71 356 365 I-chronic_disease
that 72 76 366 370 O
could 77 82 371 376 O
affect 83 89 377 383 O
the 90 93 384 387 O
absorption 94 104 388 398 O
of 105 107 399 401 O
the 108 111 402 405 O
study 112 117 406 411 B-treatment
drug 118 122 412 416 I-treatment
( 123 124 417 418 O
e.g. 124 128 418 422 O
Crohn?s 129 136 423 430 B-chronic_disease
disease 137 144 431 438 I-chronic_disease
, 144 145 438 439 O
ulcerative 146 156 440 450 B-chronic_disease
colitis 157 164 451 458 I-chronic_disease
, 164 165 458 459 O
chronic 166 173 460 467 B-chronic_disease
diarrhea 174 182 468 476 I-chronic_disease
, 182 183 476 477 O
malabsorption 184 197 478 491 B-chronic_disease
) 197 198 491 492 O

Calculated 0 10 493 503 B-clinical_variable
creatinine 11 21 504 514 I-clinical_variable
clearance 22 31 515 524 I-clinical_variable
( 32 33 525 526 I-clinical_variable
CrCl 33 37 526 530 I-clinical_variable
) 37 38 530 531 I-clinical_variable
> 39 40 532 533 O
= 40 41 533 534 O
60 42 44 535 537 B-lower_bound
mL 45 47 538 540 I-lower_bound
/ 47 48 540 541 I-lower_bound
min 48 51 541 544 I-lower_bound
calculated 52 62 545 555 O
by 63 65 556 558 O
Cockcroft 66 75 559 568 O
- 75 76 568 569 O
Gault 76 81 569 574 O
formula 82 89 575 582 O

Diagnosis 0 9 583 592 O
with 10 14 593 597 O
any 15 18 598 601 O
of 19 21 602 604 O
the 22 25 605 608 O
following 26 35 609 618 O
in 36 38 619 621 O
the 39 42 622 625 O
12 43 45 626 628 B-upper_bound
months 46 52 629 635 I-upper_bound
prior 53 58 636 641 I-upper_bound
to 59 61 642 644 O
registration 62 74 645 657 O
: 74 75 657 658 O
severe 76 82 659 665 O
/ 82 83 665 666 O
unstable 83 91 666 674 B-chronic_disease
angina 92 98 675 681 I-chronic_disease
, 98 99 681 682 O
myocardial 100 110 683 693 B-chronic_disease
infarction 111 121 694 704 I-chronic_disease
, 121 122 704 705 O
uncontrolled 123 135 706 718 O
cardiac 136 143 719 726 B-chronic_disease
arrhythmia 144 154 727 737 I-chronic_disease
, 154 155 737 738 O
congestive 156 166 739 749 B-chronic_disease
heart 167 172 750 755 I-chronic_disease
failure 173 180 756 763 I-chronic_disease
, 180 181 763 764 O
cerebrovascular 182 197 765 780 B-chronic_disease
accident 198 206 781 789 I-chronic_disease
or 207 209 790 792 O
transient 210 219 793 802 B-chronic_disease
ischemic 220 228 803 811 I-chronic_disease
attack 229 235 812 818 I-chronic_disease

ECOG 0 4 819 823 B-clinical_variable
PS 5 7 824 826 I-clinical_variable
0 8 9 827 828 B-lower_bound
- 9 10 828 829 O
1 10 11 829 830 B-upper_bound

Eastern 0 7 831 838 B-clinical_variable
Cooperative 8 19 839 850 I-clinical_variable
Oncology 20 28 851 859 I-clinical_variable
Group 29 34 860 865 I-clinical_variable
( 35 36 866 867 I-clinical_variable
ECOG 36 40 867 871 I-clinical_variable
) 40 41 871 872 I-clinical_variable
performance 42 53 873 884 I-clinical_variable
status 54 60 885 891 I-clinical_variable
( 61 62 892 893 I-clinical_variable
PS 62 64 893 895 I-clinical_variable
) 64 65 895 896 I-clinical_variable
of 66 68 897 899 O
0 69 70 900 901 B-lower_bound
- 70 71 901 902 O
2 71 72 902 903 B-upper_bound

Females 0 7 904 911 B-gender
of 8 10 912 914 O
childbearing 11 23 915 927 O
potential 24 33 928 937 O
must 34 38 938 942 O
use 39 42 943 946 B-contraception_consent
an 43 45 947 949 I-contraception_consent
effective 46 55 950 959 I-contraception_consent
method 56 62 960 966 I-contraception_consent
of 63 65 967 969 I-contraception_consent
contraception 66 79 970 983 I-contraception_consent
( 80 81 984 985 O
barrier 81 88 985 992 B-contraception_consent
method 89 95 993 999 I-contraception_consent
of 96 98 1000 1002 I-contraception_consent
birth 99 104 1003 1008 I-contraception_consent
control 105 112 1009 1016 I-contraception_consent
or 113 115 1017 1019 O
abstinence 116 126 1020 1030 B-contraception_consent
) 126 127 1030 1031 O
from 128 132 1032 1036 O
the 133 136 1037 1040 O
time 137 141 1041 1045 O
of 142 144 1046 1048 O
consent 145 152 1049 1056 O
until 153 158 1057 1062 O
at 159 161 1063 1065 O
least 162 167 1066 1071 O
180 168 171 1072 1075 B-lower_bound
days 172 176 1076 1080 I-lower_bound
following 177 186 1081 1090 O
discontinuation 187 202 1091 1106 O
of 203 205 1107 1109 O
protocol 206 214 1110 1118 O
therapy 215 222 1119 1126 B-treatment

Fresh 0 5 1127 1132 O
tumor 6 11 1133 1138 B-treatment
biopsies 12 20 1139 1147 I-treatment
from 21 25 1148 1152 O
metastatic 26 36 1153 1163 B-cancer
or 37 39 1164 1166 I-cancer
primary 40 47 1167 1174 I-cancer
tumor 48 53 1175 1180 I-cancer
lesions 54 61 1181 1188 I-cancer
will 62 66 1189 1193 O
be 67 69 1194 1196 O
done 70 74 1197 1201 O
only 75 79 1202 1206 O
if 80 82 1207 1209 O
considered 83 93 1210 1220 O
safe 94 98 1221 1225 O
and 99 102 1226 1229 O
feasible 103 111 1230 1238 O
by 112 114 1239 1241 O
treating 115 123 1242 1250 O
physician 124 133 1251 1260 O
and 134 137 1261 1264 O
radiologist 138 149 1265 1276 O

Gastrointestinal 0 16 1277 1293 B-chronic_disease
tract 17 22 1294 1299 I-chronic_disease
disease 23 30 1300 1307 I-chronic_disease
or 31 33 1308 1310 O
any 34 37 1311 1314 O
other 38 43 1315 1320 O
reasons 44 51 1321 1328 O
resulting 52 61 1329 1338 O
in 62 64 1339 1341 O
an 65 67 1342 1344 O
inability 68 77 1345 1354 O
to 78 80 1355 1357 O
take 81 85 1358 1362 O
oral 86 90 1363 1367 B-treatment
medication 91 101 1368 1378 I-treatment
or 102 104 1379 1381 O
a 105 106 1382 1383 O
requirement 107 118 1384 1395 O
for 119 122 1396 1399 O
intravenous 123 134 1400 1411 B-treatment
( 135 136 1412 1413 I-treatment
IV 136 138 1413 1415 I-treatment
) 138 139 1415 1416 I-treatment
alimentation 140 152 1417 1429 I-treatment
, 152 153 1429 1430 O
prior 154 159 1431 1436 B-treatment
surgical 160 168 1437 1445 I-treatment
procedures 169 179 1446 1456 I-treatment
affecting 180 189 1457 1466 O
absorption 190 200 1467 1477 O
, 200 201 1477 1478 O
active 202 208 1479 1485 O
peptic 209 215 1486 1492 B-chronic_disease
ulcer 216 221 1493 1498 I-chronic_disease
disease 222 229 1499 1506 I-chronic_disease
or 230 232 1507 1509 O
chronic 233 240 1510 1517 B-chronic_disease
diarrhea 241 249 1518 1526 I-chronic_disease

Hemoglobin 0 10 1527 1537 B-clinical_variable
> 11 12 1538 1539 O
= 12 13 1539 1540 O
9 14 15 1541 1542 B-lower_bound
gm 16 18 1543 1545 I-lower_bound
/ 18 19 1545 1546 I-lower_bound
dL 19 21 1546 1548 I-lower_bound

Histologically 0 14 1549 1563 O
confirmed 15 24 1564 1573 O
refractory 25 35 1574 1584 O
locally 36 43 1585 1592 O
- 43 44 1592 1593 O
advanced 44 52 1593 1601 O
unresectable 53 65 1602 1614 O
or 66 68 1615 1617 O
metastatic 69 79 1618 1628 B-cancer
pancreatic 80 90 1629 1639 I-cancer
or 91 93 1640 1642 O
biliary 94 101 1643 1650 B-cancer
cancer 102 108 1651 1657 I-cancer

Histologically 0 14 1658 1672 O
confirmed 15 24 1673 1682 O
solid 25 30 1683 1688 B-cancer
tumor 31 36 1689 1694 I-cancer
malignancy 37 47 1695 1705 O

History 0 7 1706 1713 O
of 8 10 1714 1716 O
bone 11 15 1717 1721 B-treatment
marrow 16 22 1722 1728 I-treatment
transplant 23 33 1729 1739 I-treatment
and 34 37 1740 1743 O
stem 38 42 1744 1748 B-treatment
cell 43 47 1749 1753 I-treatment
rescue 48 54 1754 1760 I-treatment

Known 0 5 1761 1766 O
active 6 12 1767 1773 O
hepatitis 13 22 1774 1783 B-chronic_disease
B 23 24 1784 1785 I-chronic_disease
infection 25 34 1786 1795 I-chronic_disease
( 35 36 1796 1797 O
defined 36 43 1797 1804 O
as 44 46 1805 1807 O
presence 47 55 1808 1816 O
of 56 58 1817 1819 O
hepatitis 59 68 1820 1829 B-chronic_disease
B 69 70 1830 1831 I-chronic_disease
[ 71 72 1832 1833 I-chronic_disease
HepB 72 76 1833 1837 I-chronic_disease
] 76 77 1837 1838 I-chronic_disease
surface 78 85 1839 1846 O
antigen 86 93 1847 1854 O
[ 94 95 1855 1856 O
sAg 95 98 1856 1859 O
] 98 99 1859 1860 O
and/or 100 106 1861 1867 O
Hep 107 110 1868 1871 O
B 111 112 1872 1873 O
deoxyribonucleic 113 129 1874 1890 O
acid 130 134 1891 1895 O
[ 135 136 1896 1897 O
DNA 136 139 1897 1900 O
] 139 140 1900 1901 O
) 140 141 1901 1902 O
, 141 142 1902 1903 O
known 143 148 1904 1909 O
active 149 155 1910 1916 O
hepatitis 156 165 1917 1926 B-chronic_disease
C 166 167 1927 1928 I-chronic_disease
infection 168 177 1929 1938 I-chronic_disease
( 178 179 1939 1940 O
defined 179 186 1940 1947 O
as 187 189 1948 1950 O
presence 190 198 1951 1959 O
of 199 201 1960 1962 O
hepatitis 202 211 1963 1972 B-chronic_disease
C 212 213 1973 1974 I-chronic_disease
[ 214 215 1975 1976 I-chronic_disease
Hep 215 218 1976 1979 I-chronic_disease
C 219 220 1980 1981 I-chronic_disease
] 220 221 1981 1982 I-chronic_disease
ribonucleic 222 233 1983 1994 O
acid 234 238 1995 1999 O
[ 239 240 2000 2001 O
RNA 240 243 2001 2004 O
] 243 244 2004 2005 O
) 244 245 2005 2006 O
and/or 246 252 2007 2013 O
known 253 258 2014 2019 O
human 259 264 2020 2025 B-chronic_disease
immunodeficiency 265 281 2026 2042 I-chronic_disease
virus 282 287 2043 2048 I-chronic_disease
( 288 289 2049 2050 I-chronic_disease
HIV 289 292 2050 2053 I-chronic_disease
) 292 293 2053 2054 I-chronic_disease
carrier 294 301 2055 2062 O

Known 0 5 2063 2068 O
pre 6 9 2069 2072 O
- 9 10 2072 2073 O
existing 10 18 2073 2081 O
interstitial 19 31 2082 2094 B-chronic_disease
lung 32 36 2095 2099 I-chronic_disease
disease 37 44 2100 2107 I-chronic_disease

Life 0 4 2108 2112 B-clinical_variable
expectancy 5 15 2113 2123 I-clinical_variable
> 16 17 2124 2125 O
= 17 18 2125 2126 O
12 19 21 2127 2129 B-lower_bound
weeks 22 27 2130 2135 I-lower_bound

Major 0 5 2136 2141 B-treatment
surgery 6 13 2142 2149 I-treatment
within 14 20 2150 2156 O
4 21 22 2157 2158 B-upper_bound
weeks 23 28 2159 2164 I-upper_bound
before 29 35 2165 2171 O
starting 36 44 2172 2180 O
study 45 50 2181 2186 B-treatment
treatment 51 60 2187 2196 I-treatment
or 61 63 2197 2199 O
scheduled 64 73 2200 2209 O
for 74 77 2210 2213 O
surgery 78 85 2214 2221 O
during 86 92 2222 2228 O
the 93 96 2229 2232 O
projected 97 106 2233 2242 O
course 107 113 2243 2249 O
of 114 116 2250 2252 O
the 117 120 2253 2256 O
study 121 126 2257 2262 O

Measurable 0 10 2263 2273 B-chronic_disease
disease 11 18 2274 2281 I-chronic_disease
according 19 28 2282 2291 O
to 29 31 2292 2294 O
Response 32 40 2295 2303 O
Evaluation 41 51 2304 2314 O
Criteria 52 60 2315 2323 O
in 61 63 2324 2326 O
Solid 64 69 2327 2332 O
Tumors 70 76 2333 2339 O
( 77 78 2340 2341 O
RECIST 78 84 2341 2347 O
) 84 85 2347 2348 O
version 86 93 2349 2356 O
( 94 95 2357 2358 O
v)1.1 95 100 2358 2363 O

Must 0 4 2364 2368 O
be 5 7 2369 2371 O
willing 8 15 2372 2379 O
to 16 18 2380 2382 O
provide 19 26 2383 2390 O
tumor 27 32 2391 2396 B-cancer
tissue 33 39 2397 2403 O
biopsy 40 46 2404 2410 B-treatment
samples 47 54 2411 2418 O
( 55 56 2419 2420 O
may 56 59 2420 2423 O
be 60 62 2424 2426 O
fresh 63 68 2427 2432 O
or 69 71 2433 2435 O
archival 72 80 2436 2444 O
paraffin 81 89 2445 2453 O
embedded 90 98 2454 2462 O
) 98 99 2462 2463 O
at 100 102 2464 2466 O
baseline 103 111 2467 2475 O

No 0 2 2476 2478 O
limit 3 8 2479 2484 O
on 9 11 2485 2487 O
the 12 15 2488 2491 O
number 16 22 2492 2498 O
of 23 25 2499 2501 O
prior 26 31 2502 2507 B-treatment
systemic 32 40 2508 2516 I-treatment
therapies 41 50 2517 2526 I-treatment
for 51 54 2527 2530 O
metastatic 55 65 2531 2541 B-cancer
disease 66 73 2542 2549 I-cancer

No 0 2 2550 2552 O
prior 3 8 2553 2558 B-treatment
treatment 9 18 2559 2568 I-treatment
with 19 23 2569 2573 I-treatment
erlotinib 24 33 2574 2583 I-treatment
is 34 36 2584 2586 O
allowed 37 44 2587 2594 O
for 45 48 2595 2598 O
pancreatic 49 59 2599 2609 B-cancer
cancer 60 66 2610 2616 I-cancer
patients 67 75 2617 2625 O

PT 0 2 2626 2628 B-clinical_variable
( 3 4 2629 2630 O
or 4 6 2630 2632 O
INR 7 10 2633 2636 B-clinical_variable
) 10 11 2636 2637 O
and 12 15 2638 2641 O
PTT 16 19 2642 2645 B-clinical_variable
= 20 21 2646 2647 O
< 21 22 2647 2648 O
1.5 23 26 2649 2652 B-upper_bound
x 27 28 2653 2654 I-upper_bound
ULN 29 32 2655 2658 I-upper_bound

Patients 0 8 2659 2667 O
in 9 11 2668 2670 O
the 12 15 2671 2674 O
expansion 16 25 2675 2684 O
cohort 26 32 2685 2691 O
must 33 37 2692 2696 O
have 38 42 2697 2701 O
a 43 44 2702 2703 O
measurable 45 55 2704 2714 O
site 56 60 2715 2719 O
of 61 63 2720 2722 O
disease 64 71 2723 2730 O
according 72 81 2731 2740 O
to 82 84 2741 2743 O
RECIST 85 91 2744 2750 O
( 92 93 2751 2752 O
v 93 94 2752 2753 O
1.1 95 98 2754 2757 O
) 98 99 2757 2758 O
that 100 104 2759 2763 O
has 105 108 2764 2767 O
not 109 112 2768 2771 O
been 113 117 2772 2776 O
previously 118 128 2777 2787 O
irradiated 129 139 2788 2798 O
, 139 140 2798 2799 O
or 141 143 2800 2802 O
evidence 144 152 2803 2811 O
of 153 155 2812 2814 O
at 156 158 2815 2817 O
least 159 164 2818 2823 O
20 165 167 2824 2826 B-lower_bound
% 167 168 2826 2827 I-lower_bound
progression 169 180 2828 2839 O
in 181 183 2840 2842 O
a 184 185 2843 2844 O
previously 186 196 2845 2855 O
irradiated 197 207 2856 2866 O
lesion 208 214 2867 2873 O
, 214 215 2873 2874 O
and 216 219 2875 2878 O
assessed 220 228 2879 2887 O
by 229 231 2888 2890 O
imaging 232 239 2891 2898 O
within 240 246 2899 2905 O
28 247 249 2906 2908 B-upper_bound
days 250 254 2909 2913 I-upper_bound
prior 255 260 2914 2919 I-upper_bound
to 261 263 2920 2922 O
registration 264 276 2923 2935 O
for 277 280 2936 2939 O
protocol 281 289 2940 2948 B-treatment
therapy 290 297 2949 2956 I-treatment

Patients 0 8 2957 2965 O
who 9 12 2966 2969 O
already 13 20 2970 2977 O
have 21 25 2978 2982 O
OncoPlex 26 34 2983 2991 B-treatment
or 35 37 2992 2994 O
other 38 43 2995 3000 O
equivalent 44 54 3001 3011 O
gene 55 59 3012 3016 O
sequencing 60 70 3017 3027 O
assay 71 76 3028 3033 O
( 77 78 3034 3035 O
eg 78 80 3035 3037 O
Foundation 81 91 3038 3048 O
One 92 95 3049 3052 O
, 95 96 3052 3053 O
Perthera 97 105 3054 3062 O
, 105 106 3062 3063 O
Caris 107 112 3064 3069 O
etc 113 116 3070 3073 O
) 116 117 3073 3074 O
test 118 122 3075 3079 O
results 123 130 3080 3087 O
available 131 140 3088 3097 O
from 141 145 3098 3102 O
prior 146 151 3103 3108 B-treatment
tumor 152 157 3109 3114 I-treatment
biopsy 158 164 3115 3121 I-treatment
are 165 168 3122 3125 O
eligible 169 177 3126 3134 O
to 178 180 3135 3137 O
participate 181 192 3138 3149 O
, 192 193 3149 3150 O
without 194 201 3151 3158 O
the 202 205 3159 3162 O
needed 206 212 3163 3169 O
of 213 215 3170 3172 O
a 216 217 3173 3174 O
repeat 218 224 3175 3181 O
tumor 225 230 3182 3187 O
biopsy 231 237 3188 3194 O
, 237 238 3194 3195 O
but 239 242 3196 3199 O
the 243 246 3200 3203 O
test 247 251 3204 3208 O
results 252 259 3209 3216 O
need 260 264 3217 3221 O
to 265 267 3222 3224 O
be 268 270 3225 3227 O
provided 271 279 3228 3236 O
to 280 282 3237 3239 O
the 283 286 3240 3243 O
study 287 292 3244 3249 O
principal 293 302 3250 3259 O
investigator 303 315 3260 3272 O

Platelet 0 8 3273 3281 B-treatment
count 9 14 3282 3287 I-treatment
> 15 16 3288 3289 O
= 16 17 3289 3290 O
100,000 18 25 3291 3298 B-lower_bound
/ 25 26 3298 3299 I-lower_bound
uL 26 28 3299 3301 I-lower_bound

Prior 0 5 3302 3307 B-treatment
treatment 6 15 3308 3317 I-treatment
with 16 20 3318 3322 I-treatment
afatinib 21 29 3323 3331 I-treatment

Prior 0 5 3332 3337 B-treatment
treatment 6 15 3338 3347 I-treatment
with 16 20 3348 3352 I-treatment
erlotinib 21 30 3353 3362 I-treatment
, 30 31 3362 3363 O
gefitinib 32 41 3364 3373 B-treatment
or 42 44 3374 3376 O
EGFR 45 49 3377 3381 B-treatment
- 49 50 3381 3382 I-treatment
blocking 50 58 3382 3390 I-treatment
monoclonal 59 69 3391 3401 I-treatment
antibodies 70 80 3402 3412 I-treatment
( 81 82 3413 3414 O
cetuximab 82 91 3414 3423 B-treatment
and 92 95 3424 3427 O
panitumumab 96 107 3428 3439 B-treatment
) 107 108 3439 3440 O

Prothrombin 0 11 3441 3452 B-treatment
time 12 16 3453 3457 I-treatment
( 17 18 3458 3459 I-treatment
PT 18 20 3459 3461 I-treatment
) 20 21 3461 3462 I-treatment
( 22 23 3463 3464 O
or 23 25 3464 3466 O
international 26 39 3467 3480 B-clinical_variable
normalized 40 50 3481 3491 I-clinical_variable
ratio 51 56 3492 3497 I-clinical_variable
[ 57 58 3498 3499 I-clinical_variable
INR 58 61 3499 3502 I-clinical_variable
] 61 62 3502 3503 I-clinical_variable
) 62 63 3503 3504 O
and 64 67 3505 3508 O
partial 68 75 3509 3516 B-clinical_variable
thromboplastin 76 90 3517 3531 I-clinical_variable
time 91 95 3532 3536 I-clinical_variable
( 96 97 3537 3538 I-clinical_variable
PTT 97 100 3538 3541 I-clinical_variable
) 100 101 3541 3542 I-clinical_variable
= 102 103 3543 3544 O
< 103 104 3544 3545 O
1.5 105 108 3546 3549 B-upper_bound
x 109 110 3550 3551 I-upper_bound
ULN 111 114 3552 3555 I-upper_bound

Radiotherapy 0 12 3556 3568 B-treatment
within 13 19 3569 3575 O
4 20 21 3576 3577 B-upper_bound
weeks 22 27 3578 3583 I-upper_bound
prior 28 33 3584 3589 I-upper_bound
to 34 36 3590 3592 O
therapy 37 44 3593 3600 O
except 45 51 3601 3607 O
palliative 52 62 3608 3618 O
radiation 63 72 3619 3628 B-treatment
to 73 75 3629 3631 O
target 76 82 3632 3638 O
organs 83 89 3639 3645 O
other 90 95 3646 3651 O
than 96 100 3652 3656 O
primary 101 108 3657 3664 B-cancer
tumor 109 114 3665 3670 I-cancer
may 115 118 3671 3674 O
be 119 121 3675 3677 O
allowed 122 129 3678 3685 O
up 130 132 3686 3688 O
to 133 135 3689 3691 O
2 136 137 3692 3693 B-upper_bound
weeks 138 143 3694 3699 I-upper_bound
prior 144 149 3700 3705 I-upper_bound
to 150 152 3706 3708 O
registration 153 165 3709 3721 O

Receipt 0 7 3722 3729 O
of 8 10 3730 3732 O
any 11 14 3733 3736 O
chemotherapy 15 27 3737 3749 B-treatment
, 27 28 3749 3750 O
biological 29 39 3751 3761 B-treatment
therapy 40 47 3762 3769 I-treatment
or 48 50 3770 3772 O
investigational 51 66 3773 3788 B-treatment
agents 67 73 3789 3795 I-treatment
within 74 80 3796 3802 O
3 81 82 3803 3804 B-upper_bound
weeks 83 88 3805 3810 I-upper_bound
prior 89 94 3811 3816 I-upper_bound
to 95 97 3817 3819 O
study 98 103 3820 3825 O
registration 104 116 3826 3838 O

Sexually 0 8 3839 3847 O
active 9 15 3848 3854 O
male 16 20 3855 3859 B-gender
subjects 21 29 3860 3868 I-gender
must 30 34 3869 3873 O
use 35 38 3874 3877 B-contraception_consent
an 39 41 3878 3880 I-contraception_consent
effective 42 51 3881 3890 I-contraception_consent
method 52 58 3891 3897 I-contraception_consent
of 59 61 3898 3900 I-contraception_consent
contraception 62 75 3901 3914 I-contraception_consent
( 76 77 3915 3916 O
barrier 77 84 3916 3923 O
method 85 91 3924 3930 O
of 92 94 3931 3933 O
birth 95 100 3934 3939 O
control 101 108 3940 3947 O
or 109 111 3948 3950 O
abstinence 112 122 3951 3961 O
) 122 123 3961 3962 O
from 124 128 3963 3967 O
the 129 132 3968 3971 O
time 133 137 3972 3976 O
of 138 140 3977 3979 O
consent 141 148 3980 3987 O
until 149 154 3988 3993 O
at 155 157 3994 3996 O
least 158 163 3997 4002 O
180 164 167 4003 4006 B-lower_bound
days 168 172 4007 4011 I-lower_bound
following 173 182 4012 4021 O
discontinuation 183 198 4022 4037 O
of 199 201 4038 4040 O
protocol 202 210 4041 4049 O
therapy 211 218 4050 4057 B-treatment

Total 0 5 4058 4063 B-clinical_variable
bilirubin 6 15 4064 4073 I-clinical_variable
= 16 17 4074 4075 O
< 17 18 4075 4076 O
1.5 19 22 4077 4080 B-upper_bound
times 23 28 4081 4086 I-upper_bound
upper 29 34 4087 4092 I-upper_bound
limit 35 40 4093 4098 I-upper_bound
of 41 43 4099 4101 I-upper_bound
normal 44 50 4102 4108 I-upper_bound
( 51 52 4109 4110 I-upper_bound
ULN 52 55 4110 4113 I-upper_bound
) 55 56 4113 4114 I-upper_bound

Transaminases 0 13 4115 4128 O
( 14 15 4129 4130 O
AST 15 18 4130 4133 B-clinical_variable
and/or 19 25 4134 4140 O
ALT 26 29 4141 4144 B-clinical_variable
) 29 30 4144 4145 O
= 31 32 4146 4147 O
< 32 33 4147 4148 O
2.5 34 37 4149 4152 B-upper_bound
x 38 39 4153 4154 I-upper_bound
ULN 40 43 4155 4158 I-upper_bound

Transaminases 0 13 4159 4172 B-clinical_variable
( 14 15 4173 4174 I-clinical_variable
aspartate 15 24 4174 4183 I-clinical_variable
aminotransferase 25 41 4184 4200 I-clinical_variable
[ 42 43 4201 4202 I-clinical_variable
AST 43 46 4202 4205 I-clinical_variable
] 46 47 4205 4206 I-clinical_variable
and/or 48 54 4207 4213 I-clinical_variable
alanine 55 62 4214 4221 I-clinical_variable
aminotransferase 63 79 4222 4238 I-clinical_variable
[ 80 81 4239 4240 I-clinical_variable
ALT 81 84 4240 4243 I-clinical_variable
] 84 85 4243 4244 I-clinical_variable
) 85 86 4244 4245 I-clinical_variable
= 87 88 4246 4247 O
< 88 89 4247 4248 O
2.5 90 93 4249 4252 B-upper_bound
x 94 95 4253 4254 I-upper_bound
ULN 96 99 4255 4258 I-upper_bound

Untreated 0 9 4259 4268 O
or 10 12 4269 4271 O
symptomatic 13 24 4272 4283 O
brain 25 30 4284 4289 B-cancer
metastases 31 41 4290 4300 I-cancer
requiring 42 51 4301 4310 O
corticosteroid 52 66 4311 4325 B-treatment
therapy 67 74 4326 4333 I-treatment
( 75 76 4334 4335 O
no 76 78 4335 4337 O
corticosteroid 79 93 4338 4352 O
use 94 97 4353 4356 O
for 98 101 4357 4360 O
this 102 106 4361 4365 O
purpose 107 114 4366 4373 O
in 115 117 4374 4376 O
the 118 121 4377 4380 O
preceding 122 131 4381 4390 O
4 132 133 4391 4392 B-upper_bound
weeks 134 139 4393 4398 I-upper_bound
) 139 140 4398 4399 O

females 0 7 4400 4407 B-gender
must 8 12 4408 4412 B-pregnancy
not 13 16 4413 4416 I-pregnancy
be 17 19 4417 4419 I-pregnancy
pregnant 20 28 4420 4428 I-pregnancy
or 29 31 4429 4431 O
breastfeeding 32 45 4432 4445 O

females 0 7 4446 4453 B-gender
of 8 10 4454 4456 O
childbearing 11 23 4457 4469 O
potential 24 33 4470 4479 O
must 34 38 4480 4484 O
have 39 43 4485 4489 O
a 44 45 4490 4491 O
negative 46 54 4492 4500 B-pregnancy
pregnancy 55 64 4501 4510 I-pregnancy
test 65 69 4511 4515 O
within 70 76 4516 4522 O
3 77 78 4523 4524 B-upper_bound
days 79 83 4525 4529 I-upper_bound
prior 84 89 4530 4535 O
to 90 92 4536 4538 O
registration 93 105 4539 4551 O
for 106 109 4552 4555 O
protocol 110 118 4556 4564 B-treatment
therapy 119 126 4565 4572 I-treatment

in 0 2 4573 4575 O
rare 3 7 4576 4580 O
cases 8 13 4581 4586 O
of 14 16 4587 4589 O
an 17 19 4590 4592 O
endocrine 20 29 4593 4602 O
- 29 30 4602 4603 O
secreting 30 39 4603 4612 O
tumor 40 45 4613 4618 B-cancer
, 45 46 4618 4619 O
human 47 52 4620 4625 O
chorionic 53 62 4626 4635 O
gonadotropin 63 75 4636 4648 O
( 76 77 4649 4650 O
hCG 77 80 4650 4653 O
) 80 81 4653 4654 O
levels 82 88 4655 4661 O
may 89 92 4662 4665 O
be 93 95 4666 4668 O
above 96 101 4669 4674 O
normal 102 108 4675 4681 O
limits 109 115 4682 4688 O
( 116 117 4689 4690 O
falsely 117 124 4690 4697 O
- 124 125 4697 4698 O
positive 125 133 4698 4706 O
) 133 134 4706 4707 O
but 135 138 4708 4711 O
with 139 143 4712 4716 O
no 144 146 4717 4719 O
pregnancy 147 156 4720 4729 B-pregnancy
in 157 159 4730 4732 O
the 160 163 4733 4736 O
patient 164 171 4737 4744 O

patients 0 8 4745 4753 O
who 9 12 4754 4757 O
already 13 20 4758 4765 O
have 21 25 4766 4770 O
OncoPlex 26 34 4771 4779 B-treatment
or 35 37 4780 4782 O
other 38 43 4783 4788 O
equivalent 44 54 4789 4799 O
gene 55 59 4800 4804 B-treatment
sequencing 60 70 4805 4815 I-treatment
assay 71 76 4816 4821 I-treatment
( 77 78 4822 4823 O
eg 78 80 4823 4825 O
Foundation 81 91 4826 4836 O
One 92 95 4837 4840 O
, 95 96 4840 4841 O
Perthera 97 105 4842 4850 O
, 105 106 4850 4851 O
Caris 107 112 4852 4857 O
etc 113 116 4858 4861 O
) 116 117 4861 4862 O
test 118 122 4863 4867 O
results 123 130 4868 4875 O
available 131 140 4876 4885 O
from 141 145 4886 4890 O
prior 146 151 4891 4896 B-treatment
tumor 152 157 4897 4902 I-treatment
biopsy 158 164 4903 4909 I-treatment
are 165 168 4910 4913 O
eligible 169 177 4914 4922 O
to 178 180 4923 4925 O
participate 181 192 4926 4937 O
, 192 193 4937 4938 O
without 194 201 4939 4946 O
the 202 205 4947 4950 O
needed 206 212 4951 4957 O
of 213 215 4958 4960 O
a 216 217 4961 4962 O
repeat 218 224 4963 4969 O
tumor 225 230 4970 4975 O
biopsy 231 237 4976 4982 O
, 237 238 4982 4983 O
but 239 242 4984 4987 O
the 243 246 4988 4991 O
test 247 251 4992 4996 O
results 252 259 4997 5004 O
need 260 264 5005 5009 O
to 265 267 5010 5012 O
be 268 270 5013 5015 O
available 271 280 5016 5025 O
to 281 283 5026 5028 O
the 284 287 5029 5032 O
study 288 293 5033 5038 O
principal 294 303 5039 5048 O
investigator 304 316 5049 5061 O

there 0 5 5062 5067 O
should 6 12 5068 5074 O
be 13 15 5075 5077 O
a 16 17 5078 5079 O
repeat 18 24 5080 5086 O
serum 25 30 5087 5092 O
hCG 31 34 5093 5096 O
test 35 39 5097 5101 O
( 40 41 5102 5103 O
with 41 45 5103 5107 O
a 46 47 5108 5109 O
non 48 51 5110 5113 O
- 51 52 5113 5114 O
rising 52 58 5114 5120 O
result 59 65 5121 5127 O
) 65 66 5127 5128 O
to 67 69 5129 5131 O
rule 70 74 5132 5136 O
out 75 78 5137 5140 O
pregnancy 79 88 5141 5150 B-pregnancy

